Relacorilant targets glucocorticoid receptor proteins, potentially redefining treatment for platinum-resistant ovarian cancer by inhibiting cancer cell proliferation. Clinical trials show relacorilant ...
ETX-19477 is a potent, selective inhibitor of poly (ADP-ribose) glycohydrolase (PARG), an enzyme that plays a role in the DNA ...
University of Manchester researchers have shown that analysis of fluid flushed through a fallopian tube holds promise for ...
InvestorsHub on MSN
BioVaxys posts encouraging ovarian cancer data from MVP-S combo trial
BioVaxys Technology Corp. (CSE:BIOV) (USOTC:BVAXF) said it has reported positive early results from its Phase 1B/2 PESCO ...
Scientists from University of California, Los Angeles, Harvard University, and elsewhere have developed what they claim is the first comprehensive road map of how the ovarian reserve forms in primates ...
ARTISTRY-7 trial showed no significant survival benefit for nemvaleukin and Keytruda over chemotherapy in platinum-resistant ovarian cancer. Mural Oncology will cease nemvaleukin development for this ...
A microscopy image of the outer region of the rhesus macaque ovary. The developing egg cells are marked by VASA protein (green) and surrounded by supporting granulosa cells marked by FOXL2 (magenta) ...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (ADTX) ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback